$24.000
-0.653 (-2.72%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
DNLI 相似圖表分析預測
Alphio's DNLI stock price prediction model matches the current Denali Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $23.61 (-1.61%). The 1-week path is $24.72 (+2.98%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Denali Therapeutics Inc 股票嗎？
Denali Therapeutics Inc (DNLI) is a good buy right now due to its recent revenue growth of $3.6 million in Q2 2026, which exceeded expectations by $1.41 million, and a gross margin of 76.61%, indicating strong profitability potential. However, the main risk is the negative net income margin of -3539.21%, which reflects ongoing losses that investors should consider.
DNLI 股價於 Friday 收在 $24.00，此前下跌 -2.72%
Denali Therapeutics Inc (DNLI) last closed at $24, losing -2.72%. These facts feed the 1-day and 1-week DNLI price prediction above.
分析師一致預期
Denali Therapeutics Inc（DNLI）：買進 3、持有 1、賣出 0。展望：Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
預測驅動因素
Denali Therapeutics Inc（DNLI）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
相似圖表形態
近期走勢與 DNLI 最接近的股票，依相似度排序。
DNLI 季節性分析
Historically the probability of a positive August return for DNLI is 66.67%. August offers the highest probability of a positive month at 66.67%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。